ConductScience.org, home

Paper33492425

Overdiagnosis in urologic cancer : For World Journal of Urology Symposium on active surveillance in prostate and renal cancer.

Klotz L. World J Urol, 2022. Cited by 24 papers, by iCite.

Cite this record

ConductScience Library. Overdiagnosis in urologic cancer : For World Journal of Urology Symposium on active surveillance in prostate and renal cancer. Papers, record 33492425. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33492425

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Overdiagnosis in urologic cancer : For World Journal of Urology Symposium on active surveillance in prostate and renal cancer.
PubMed
Journal
World J Urol
PubMed
Year
2022
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
24
iCite
Relative citation ratio, by iCite
1.85
iCite
Revised in PubMed
2026-10-10
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Klotz LLaurencehttps://orcid.org/0000-0003-1001-2235

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
OverdiagnosisMajor topic
Urologic NeoplasmsMajor topic
Congresses as Topic
Early Detection of Cancer
Humans
Male
Periodicals as Topic
Watchful Waiting

Source PubMed

Download CSV of topics

References53

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
130413793Active surveillance for prostate and thyroid cancers: evolution in clinical paradigms and lessons learned.Nat Rev Clin Oncol2019https://conductscience.org/library/papers/30413793PubMed
216244247Guidelines for management of small pulmonary nodules detected on CT scans: a statement from the Fleischner Society.Radiology2005https://conductscience.org/library/papers/16244247PubMed
332112055All change in the prostate cancer diagnostic pathway.Nat Rev Clin Oncol2020https://conductscience.org/library/papers/32112055PubMed
426166626A Contemporary Prostate Cancer Grading System: A Validated Alternative to the Gleason Score.Eur Urol2016https://conductscience.org/library/papers/26166626PubMed
525954986Role of fear in overdiagnosis and overtreatment--an essay by Iona Heath.BMJ2014https://conductscience.org/library/papers/25954986PubMed
626687318Long-term oncological outcomes of an active surveillance program in recurrent low grade Ta bladder cancer.Urol Oncol2016https://conductscience.org/library/papers/26687318PubMed
717600614Clinicopathologic features of prostate adenocarcinoma incidentally discovered at the time of radical cystectomy: an evidence-based analysis.Eur Urol2007https://conductscience.org/library/papers/17600614PubMed
82408737Occult papillary carcinoma of the thyroid. A "normal" finding in Finland. A systematic autopsy study.Cancer1985https://conductscience.org/library/papers/2408737PubMed
98973422Where should neuroblastoma mass screening go?Lancet1996https://conductscience.org/library/papers/8973422PubMed
1010086448Analysis of the melanoma epidemic, both apparent and real: data from the 1973 through 1994 surveillance, epidemiology, and end results program registry.Arch Dermatol1999https://conductscience.org/library/papers/10086448PubMed
1119297565Mortality results from a randomized prostate-cancer screening trial.N Engl J Med2009https://conductscience.org/library/papers/19297565PubMed
1226441345Thyroid Cancer Detection by Ultrasound Among Residents Ages 18 Years and Younger in Fukushima, Japan: 2011 to 2014.Epidemiology2016https://conductscience.org/library/papers/26441345PubMed
1327532827Worldwide Thyroid-Cancer Epidemic? The Increasing Impact of Overdiagnosis.N Engl J Med2016https://conductscience.org/library/papers/27532827PubMed
1424162944Overdiagnosis: when good intentions meet vested interests--an essay by Iona Heath.BMJ2013https://conductscience.org/library/papers/24162944PubMed
1527324428EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016.Eur Urol2017https://conductscience.org/library/papers/27324428PubMed
1625740625The challenge of overdiagnosis begins with its definition.BMJ2015https://conductscience.org/library/papers/25740625PubMed
1723847245Prevalence of prostate cancer on autopsy: cross-sectional study on unscreened Caucasian and Asian men.J Natl Cancer Inst2013https://conductscience.org/library/papers/23847245PubMed
1820413742Overdiagnosis in cancer.J Natl Cancer Inst2010https://conductscience.org/library/papers/20413742PubMed
1916517548Rate of over-diagnosis of breast cancer 15 years after end of Malmö mammographic screening trial: follow-up study.BMJ2006https://conductscience.org/library/papers/16517548PubMed
2019297566Screening and prostate-cancer mortality in a randomized European study.N Engl J Med2009https://conductscience.org/library/papers/19297566PubMed

See all 53 referencesDownload CSV of references

Cited by20

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 24 citations.

PMIDTitleJournalYearIn PapersSource
42801144Patients with high-risk features on active surveillance for prostate cancer.Prostate Int2026https://conductscience.org/library/papers/42801144PubMed
42375717Does body mass index affect the proper pre-operative grade and stage assessment in patients with prostate cancer undergoing radical prostatectomy?Cent European J Urol2026https://conductscience.org/library/papers/42375717PubMed
42136976The evolving role of PSA in prostate cancer screening: revisiting the evidence in the era of personalized medicine.Adv Lab Med2026https://conductscience.org/library/papers/42136976PubMed
41698790Patient-reported outcomes: active surveillance vs radical therapies in low-risk prostate cancer.BJU Int2026https://conductscience.org/library/papers/41698790PubMed
41594172Predictive Biomarkers for Asymptomatic Adults: Opportunities, Risks, and Guidance for General Practice.Diagnostics (Basel)2026https://conductscience.org/library/papers/41594172PubMed
40940959Oncological Efficacy and Safety of Minimally Invasive Focal and Whole-Gland Interventions in the Treatment of Low- and Intermediate-Risk Prostate Cancer: A Systematic Review and Meta-Analysis.Cancers (Basel)2025https://conductscience.org/library/papers/40940959PubMed
40429574PSMA PET as a Tool for Active Surveillance of Prostate Cancer-Where Are We at?J Clin Med2025https://conductscience.org/library/papers/40429574PubMed
40100608Perceptions, Knowledge, and Attitudes of General Population About Prostate Cancer-Associated Risk Factors: A Systematic Review of Qualitative Studies Focusing on Lifestyle.Curr Oncol Rep2025https://conductscience.org/library/papers/40100608PubMed
39251425Active surveillance for low-risk prostate cancer with high tumor burden at biopsy: lessons learned from a contemporary radical prostatectomy cohort.World J Urol2024https://conductscience.org/library/papers/39251425PubMed
39246954Promoter Hypermethylation of the BRCA1 Gene as a Novel Biomarker for Prostate Cancer.Cureus2024https://conductscience.org/library/papers/39246954PubMed
39088086Prospective close monitoring of the effect of vascular-targeted photodynamic therapy and high intensity focused ultrasound of localized prostate cancer by multiparametric magnetic resonance imaging.World J Urol2024https://conductscience.org/library/papers/39088086PubMed
38845363Active surveillance in low- and intermediate-risk prostate cancer.Asian J Androl2024https://conductscience.org/library/papers/38845363PubMed
38491163MR-Guided Transurethral Ultrasound Ablation (TULSA)-An Emerging Minimally Invasive Treatment Option for Localised Prostate Cancer.Cardiovasc Intervent Radiol2024https://conductscience.org/library/papers/38491163PubMed
38255691
A Systematic Review on Prostate-Specific Membrane Antigen Positron Emission Tomography (PSMA PET) Evaluating Localized Low- to Intermediate-Risk Prostate Cancer: A Tool to Improve Risk Stratification for Active Surveillance?
Life (Basel)2024https://conductscience.org/library/papers/38255691PubMed
38075179A new approach to prostate cancer screening.Adv Lab Med2023https://conductscience.org/library/papers/38075179PubMed
38075164Una nueva perspectiva en el cribado del cáncer de próstata.Adv Lab Med2023https://conductscience.org/library/papers/38075164PubMed
36832081Molecular Imaging Diagnosis of Renal Cancer Using 99mTc-Sestamibi SPECT/CT and Girentuximab PET-CT-Current Evidence and Future Development of Novel Techniques.Diagnostics (Basel)2023https://conductscience.org/library/papers/36832081PubMed
36545210Population‑based prostate‑specific antigen screening for prostate cancer may have an indirect effect on early detection through opportunistic testing in Kusatsu City, Shiga, Japan.Mol Clin Oncol2023https://conductscience.org/library/papers/36545210PubMed
34533289Risk of thyroid as a first or second primary cancer. A population-based study in Italy, 1998-2012.Cancer Med2021https://conductscience.org/library/papers/34533289PubMed
34445612Analysis of Several Pathways for Efficient Killing of Prostate Cancer Stem Cells: A Central Role of NF-κB RELA.Int J Mol Sci2021https://conductscience.org/library/papers/34445612PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
NPEPPS9520PubTator's text mininghttps://conductscience.org/library/genes/9520

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/33492425

GET https://conductscience.org/api/papers/v1/33492425/references?page=2